These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 30976568)

  • 41. Current evidence for transurethral en bloc resection of non-muscle-invasive bladder cancer.
    Kramer MW; Abdelkawi IF; Wolters M; Bach T; Gross AJ; Nagele U; Conort P; Merseburger AS; Kuczyk MA; Herrmann TR
    Minim Invasive Ther Allied Technol; 2014 Aug; 23(4):206-13. PubMed ID: 24447105
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Obesity is associated with worse outcomes in patients with T1 high grade urothelial carcinoma of the bladder.
    Kluth LA; Xylinas E; Crivelli JJ; Passoni N; Comploj E; Pycha A; Chrystal J; Sun M; Karakiewicz PI; Gontero P; Lotan Y; Chun FK; Fisch M; Scherr DS; Shariat SF
    J Urol; 2013 Aug; 190(2):480-6. PubMed ID: 23376707
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Novel approaches for transurethral en-bloc resection of large bladder tumors].
    Kislyakov DA; Severgina LO; Tsarichenko DG; Rapoport LM; Korovin IA; Sorokin NI
    Urologiia; 2019 Sep; (4):105-111. PubMed ID: 31535815
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Current Evidence of Transurethral En-bloc Resection of Nonmuscle Invasive Bladder Cancer.
    Kramer MW; Altieri V; Hurle R; Lusuardi L; Merseburger AS; Rassweiler J; Struck JP; Herrmann TRW
    Eur Urol Focus; 2017 Dec; 3(6):567-576. PubMed ID: 28753835
    [TBL] [Abstract][Full Text] [Related]  

  • 45. EORTC Nomograms and Risk Groups for Predicting Recurrence, Progression, and Disease-specific and Overall Survival in Non-Muscle-invasive Stage Ta-T1 Urothelial Bladder Cancer Patients Treated with 1-3 Years of Maintenance Bacillus Calmette-Guérin.
    Cambier S; Sylvester RJ; Collette L; Gontero P; Brausi MA; van Andel G; Kirkels WJ; Silva FC; Oosterlinck W; Prescott S; Kirkali Z; Powell PH; de Reijke TM; Turkeri L; Collette S; Oddens J
    Eur Urol; 2016 Jan; 69(1):60-9. PubMed ID: 26210894
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Grading and staging of bladder carcinoma in transurethral resection specimens. Correlation with 105 matched cystectomy specimens.
    Cheng L; Neumann RM; Weaver AL; Cheville JC; Leibovich BC; Ramnani DM; Scherer BG; Nehra A; Zincke H; Bostwick DG
    Am J Clin Pathol; 2000 Feb; 113(2):275-9. PubMed ID: 10664630
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Transurethral en bloc resection with bipolar button electrode for non-muscle invasive bladder cancer.
    Zhang J; Wang L; Mao S; Liu M; Zhang W; Zhang Z; Guo Y; Huang B; Yan Y; Huang Y; Yao X
    Int Urol Nephrol; 2018 Apr; 50(4):619-623. PubMed ID: 29478198
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Potential candidates for en bloc resection among patients with primary and recurrent bladder tumours.
    Nielsen NK; Jakobsen JK; Kingo PS; Jensen JB
    Scand J Urol; 2021 Oct; 55(5):366-371. PubMed ID: 34279178
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Thulium:yttrium-aluminum-garnet laser for en bloc resection of bladder cancer: clinical and histopathologic advantages.
    Muto G; Collura D; Giacobbe A; D'Urso L; Muto GL; Demarchi A; Coverlizza S; Castelli E
    Urology; 2014 Apr; 83(4):851-5. PubMed ID: 24548711
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A pilot study to assess the safety and usefulness of combined transurethral endoscopic mucosal resection and en-bloc resection for non-muscle invasive bladder cancer.
    Hayashida Y; Miyata Y; Matsuo T; Ohba K; Sakai H; Taba M; Naito S; Taniguchi K
    BMC Urol; 2019 Jun; 19(1):56. PubMed ID: 31234817
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Evaluation of second-look transurethral resection in restaging of patients with nonmuscle-invasive bladder cancer.
    Ali MH; Ismail IY; Eltobgy A; Gobeish A
    J Endourol; 2010 Dec; 24(12):2047-50. PubMed ID: 20929433
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clinical outcomes of second transurethral resection in non-muscle invasive high-grade bladder cancer: a retrospective, multi-institutional, collaborative study.
    Kamiya N; Suzuki H; Suyama T; Kobayashi M; Fukasawa S; Sekita N; Mikami K; Nihei N; Naya Y; Ichikawa T
    Int J Clin Oncol; 2017 Apr; 22(2):353-358. PubMed ID: 27744487
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Good quality white-light transurethral resection of bladder tumours (GQ-WLTURBT) with experienced surgeons performing complete resections and obtaining detrusor muscle reduces early recurrence in new non-muscle-invasive bladder cancer: validation across time and place and recommendation for benchmarking.
    Mariappan P; Finney SM; Head E; Somani BK; Zachou A; Smith G; Mishriki SF; N'Dow J; Grigor KM;
    BJU Int; 2012 Jun; 109(11):1666-73. PubMed ID: 22044434
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Predictive Factors for Residual Cancer in Second Transurethral Resection for Non-muscle-invasive Bladder Cancer.
    Akitake M; Yamaguchi A; Shiota M; Imada K; Tatsugami K; Yokomizo A; Naito S; Eto M
    Anticancer Res; 2019 Aug; 39(8):4325-4328. PubMed ID: 31366524
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Timing and outcomes for radical cystectomy in nonmuscle invasive bladder cancer.
    Zehnder P; Thalmann GN
    Curr Opin Urol; 2013 Sep; 23(5):423-8. PubMed ID: 23880740
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Thulium Laser Endoscopic En Bloc Enucleation of Nonmuscle-Invasive Bladder Cancer.
    Migliari R; Buffardi A; Ghabin H
    J Endourol; 2015 Nov; 29(11):1258-62. PubMed ID: 26102556
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Identification of potential prognostic factors for absence of residual disease in the second resection of T1 bladder cancer.
    Czech AK; Gronostaj K; Frydrych J; Fronczek J; Przydacz M; Wiatr T; Curyło Ł; Dudek P; Gąsowski J; Chłosta PL
    Cent European J Urol; 2019; 72(3):252-257. PubMed ID: 31720026
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Results of second transurethral resection for high-grade T1 bladder cancer.
    Hashine K; Ide T; Nakashima T; Hosokawa T; Ninomiya I; Teramoto N
    Urol Ann; 2016; 8(1):10-5. PubMed ID: 26834394
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Repeat transurethral resection for non-muscle-invasive bladder cancer: a contemporary series.
    Gendy R; Delprado W; Brenner P; Brooks A; Coombes G; Cozzi P; Nash P; Patel MI
    BJU Int; 2016 Apr; 117 Suppl 4():54-9. PubMed ID: 26486968
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [INTRAOPERATIVE CONTROL OF THE EFFECTIVENESS OF TRANSURETHRAL RESECTION OF NON-MUSCLE-INVASIVE BLADDER CANCER].
    Zubkov AJ; Sitdykov JN; Nuriev LR; Sitdykova MJ
    Urologiia; 2015; (2):65-7. PubMed ID: 26237810
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.